[Lys3]-Bombesin

SKU: orb1941281

Description

[Lys3]-Bombesin is a GRPR-targeting peptide used in preclinical research for imaging prostate cancer via PET. When conjugated to specific antibodies, it can also direct immune cell-mediated cytotoxicity against small cell carcinoma in experimental models, facilitating both in vitro binding studies and in vivo tumor targeting investigations.

Research Area

Pharmacology & Drug Discovery

Key Properties

• Target: Cholecystokinin Receptor
• CAS Number: 66839-66-5
• MW: 1591.84
• Formula: C₇₁H₁₁₀N₂₂O₁₈S
• SMILES: C([C@H](NC([C@@H](NC([C@@H](NC(CNC([C@@H](NC([C@@H](NC([C@@H](NC(=O)[C@@H]1CCC(=O)N1)CCC(N)=O)=O)CCCCN)=O)CC(C)C)=O)=O)CC(N)=O)=O)CCC(N)=O)=O)C(N[C@H](C(N[C@H](C(NCC(N[C@@H](CC2=CN=CN2)C(N[C@H](C(N[C@@H](CCSC)C(N)=O)=O)CC(C)C)=O)=O)=O)C(C)C)=O)C)=O)C=3C=4C(NC3)=CC=CC4

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Compound Identifiers

PubChem CID

16138263